COVID-19 Severity in Multiple SclerosisMaria Pia Sormani, Giovanna Borriello, Giampaolo Brichetto et al.|Neurology Neuroimmunology & Neuroinflammation|2021Cited by 74
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort studyMaria Pia Sormani, Laura Brambilla, Irene Schiavetti et al.|Multiple Sclerosis Journal|2021Cited by 52
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy studySebastiano Bucello, Luca Prosperini, Pietro Annovazzi et al.|Journal of Neurology|2021Cited by 22
Effects of 2-year treatment with dimethyl fumarate on cognition and functional impairment in patients with relapsing remitting multiple sclerosisMaria Pia Amato, María Trojano, Benedetta Goretti et al.|Neurological Sciences|2020Cited by 20
Relapse‐associated worsening in a real‐life multiple sclerosis cohort: the role of age and pyramidal phenotypeAurora Zanghì, Simonetta Galgani, Paolo Bellantonio et al.|European Journal of Neurology|2023Cited by 9